Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Natasha V D V Ratnaraja

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Expert Review of Anti-Infective Therapy|October 14, 2008
Current challenges in treating MRSA: what are the options?Natasha V D V Ratnaraja, Peter M Hawkey
Clinical Infection in Practice|November 7, 2022
Best practice standards for the delivery of NHS infection services in the United KingdomNatasha V D V Ratnaraja, Angharad P Davies, Bridget L Atkins, et al.
The Journal of Antimicrobial Chemotherapy|June 18, 2021
A prospective surveillance study to determine the prevalence of 16S rRNA methyltransferase-producing Gram-negative bacteria in the UKEmma Taylor, Abhijit M Bal, Indran Balakrishnan, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Expert Review of Anti-Infective Therapy|October 14, 2008
Current challenges in treating MRSA: what are the options?Natasha V D V Ratnaraja, Peter M Hawkey
Clinical Infection in Practice|November 7, 2022
Best practice standards for the delivery of NHS infection services in the United KingdomNatasha V D V Ratnaraja, Angharad P Davies, Bridget L Atkins, et al.
The Journal of Antimicrobial Chemotherapy|June 18, 2021
A prospective surveillance study to determine the prevalence of 16S rRNA methyltransferase-producing Gram-negative bacteria in the UKEmma Taylor, Abhijit M Bal, Indran Balakrishnan, et al.
Pageof 1